Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

U.S. drug development Phase success rates, by drug classification 2006-2015

This statistic shows the probability of success for new drugs in the U.S. through the various stages of development, from January 1, 2006 to December 31, 2015, by drug classification. It was found that while non-new molecular entities had a 22.6 percent probability of success from Phase I to approval, new molecular entities had only a 6.2 percent probability of success.

Probability of success for new drugs in the U.S. by development phase between 2006 and 2015, by drug classification

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

May 2016

Region

United States

Survey time period

January 1, 2006 to December 31, 2015

Supplementary notes

* NDA - New Drug Application / BLA- Biologic License Application.
** NME - New Molecular Entity.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Clinical trials"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.